Stock C4XD C4X DISCOVERY HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company C4X Discovery Holdings plc

Equities

C4XD

GB00BQQ2RV18

Biotechnology & Medical Research

Delayed London S.E.
Other stock markets
 10:44:28 2024-04-18 am EDT 		5-day change 1st Jan Change
8.74 GBX -0.11% Intraday chart for C4X Discovery Holdings plc -9.66% -2.89%
Apr. 15 C4X Discovery shareholders approve of taking firm private AN
Mar. 27 C4X Discovery Seeks to Delist From London's AIM Amid Financial Markets Downturn MT

Business Summary

C4X Discovery Holdings plc is a drug discovery company. The Company has a portfolio ranging from early-stage target opportunities to late-stage drug discovery programs. The Company has three commercially partnered programs with one candidate in clinical development. Its portfolio focuses on treatments for immuno-inflammatory diseases. The Company’s pipeline products include MALT-1 Inhibitor, a4B7 Integrin Inhibitor, IL-17A Inhibitor, NRF-2 Activator, and others. Its target identification platform (Taxonomy3) is used to analyze complex genetic datasets to identify and characterize drug target candidates. Taxonomy3 offers the potential for patient stratification in clinical trials, ensuring patient targeting and the potential for rescuing failed clinical trials or for drug repurposing. PatientSeek is its new platform that applies the mathematical approach of Taxonomy3 to stratify patients for treatments based on their genetics.

Number of employees: 49

Sales per Business

GBP in Million2022Weight2023Weight Delta
Small Molecules for Immuno-inflammation
100.0 %
3 100.0 % 2 100.0 % -36.64%

Sales per region

GBP in Million2022Weight2023Weight Delta
United Kingdom
100.0 %
3 100.0 % 2 100.0 % -36.64%

Managers

Managers TitleAgeSince
Clive Dix CEO
 Chief Executive Officer 70 14-09-02
Bradley Hoy DFI
 Director of Finance/CFO 61 16-11-21
Nick Ray CTO
 Chief Tech/Sci/R&D Officer - 15-12-31
Emma Blaney COO
 Chief Operating Officer - 13-12-31
Bhavna Hunjan BRD
 Director/Board Member - -

Members of the board

Members of the board TitleAgeSince
Clive Dix CEO
 Chief Executive Officer 70 14-09-02
Simon Harford BRD
 Director/Board Member 64 21-04-19
Alexander Stevenson BRD
 Director/Board Member 53 14-09-02
Bradley Hoy DFI
 Director of Finance/CFO 61 16-11-21
Bhavna Hunjan BRD
 Director/Board Member - -
Natalie Walter BRD
 Director/Board Member 50 18-07-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 252,227,097 174,647,026 ( 69.24 %) 0 69.24 %

Shareholders

NameEquities%Valuation
Richard Griffiths
24.35 %
61,415,789 24.35 % 7 M p
Polar Capital LLP
17.84 %
45,000,000 17.84 % 5 M p
Lombard Odier Asset Management (Europe) Ltd.
16.57 %
41,802,971 16.57 % 5 M p
Baillie Gifford & Co.
5.675 %
14,314,028 5.675 % 2 M p
Canaccord Genuity Wealth Ltd.
4.229 %
10,666,553 4.229 % 1 M p
Octopus Investments Ltd.
3.612 %
9,110,445 3.612 % 1 M p
Legal & General Investment Management Ltd.
2.439 %
6,150,882 2.439 % 749 054 p
Investec Wealth & Investment Ltd.
2.436 %
6,145,000 2.436 % 748 338 p
Herald Investment Management Ltd.
2.432 %
6,133,333 2.432 % 746 917 p
Calculus Capital Ltd.
1.148 %
2,895,755 1.148 % 352 645 p

Company contact information

C4X Discovery Holdings Plc

Manchester One 53 Portland Street

M1 3LD, Manchester

+44 1612 355 085

http://www.c4xdiscovery.com
address C4X Discovery Holdings plc(C4XD)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Ratings for C4X Discovery Holdings plc

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0875 GBP
Average target price
0.5 GBP
Spread / Average Target
+471.43%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
C4X DISCOVERY HOLDINGS PLC Stock C4X Discovery Holdings plc
-2.89% 27.48M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.95% 41.36B
LONZA GROUP AG Stock Lonza Group AG
+44.70% 41.3B
MODERNA, INC. Stock Moderna, Inc.
+3.54% 39.61B
CELLTRION, INC. Stock Celltrion, Inc.
-15.14% 25.62B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.10% 24.09B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.65% 18.38B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+25.78% 11.85B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.21% 11.82B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.62% 11.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. C4XD Stock
  4. Company C4X Discovery Holdings plc